Search results for: 'Funding and legislation'

This is the second of a three-part series of courses designed to provide an overview to the home medical equipment provider about the seating and mobility provision process: evaluation of the client, equipment simulation, funding requirements, and selecting the proper seating equipment for a particular client. This second part of the series focuses on the simulation and funding processes.

This course contains content specific to pediatrics where appropriate.

 You should complete Part 1 of this series (REHB003a - Seating & Mobility: Evaluation) prior to taking this course, and you should complete this course before completing Part 3 (REHB003c - Seating & Mobility: Choosing a Seat Cushion and Back Support).

This is the first of a series of three courses designed to provide an overview to the home medical equipment provider about the seating and mobility provision process: evaluation of the client, equipment simulation, funding requirements, and considerations in selection of the proper seating equipment for a particular client. This course contains content specific to pediatrics where appropriate.

You should complete this course before completing parts 2 and 3: REHB003b - Seating & Mobility: Recommendation and Funding and REHB003c - Seating & Mobility: Choosing a Seat Cushion and Back Support.

This course focuses on the considerations in choosing a seat. You should complete parts 1 and 2 of this series (“REHB003a - Seating & Mobility: Evaluation” and “REHB003b - Seating & Mobility: Recommendation and Funding”) prior to taking this course.

The purpose of this course is to present health care professionals with a comprehensive understanding of the etiology, symptoms, and management of urinary incontinence which are outlined under Federal legislation – (F315) 42 CFR 483.25(d) (1) (2).

Methamphetamine addiction has grown to epidemic proportions in the United States. Chemicals used to make meth include ephedrine, pseudoephedrine, and phenylpropanolamine which are found in many cough and cold products and are known as “scheduled listed chemical products” (or SLCPs). Recent federal legislation requires all “regulated sellers” of products containing these three products to self-certify with the Drug Enforcement Administration (DEA) before selling the products. While this course does not satisfy the DEA's self-certifying requirement, it does provide the information the DEA requires in order to self-certify.

Health care personnel will enhance their understanding of elder abuse and requirements of the Elder Justice Act.